Marlborough-based medical device manufacturer Hologic has been issued a warning letter from the U.S. Food and Drug Administration concerning its BioZorb Marker, a device originally recalled in March.
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, will launch the NovaSure® V5 global endometrial ablation (GEA) device at the American Association ...
On Friday, the FDA warned against using Hologic Inc.’s (NASDAQ:HOLX) BioZorb Marker products and urged healthcare facilities to return all unused lots. This follows Hologic’s voluntary recall of the ...
ARLINGTON, Va.--(BUSINESS WIRE)--The National Evaluation System for health Technology (NEST), an initiative of the Medical Device Innovation Consortium (MDIC), is pleased to welcome Hologic, a leading ...
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland (Reuters) - The U.S. health regulator on Tuesday warned patients and healthcare providers about the ...
Marlborough, Mass.-based Hologic closed a $160 million purchase of Louisville, Colo.-based devicemaker Bolder Surgical, according to a Nov. 30 news release. The acquisition adds laparoscopic vessel ...
A new study has demonstrated the safety and clinical effectiveness of a device Hologic is developing to aid with breast surgery. The study published in the Annals of Surgical Oncology, which Hologic ...
StockStory.org on MSN
Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & Supplies - Imaging, Diagnostics Stocks In Q3
Wrapping up Q3 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics ...
A new private-label deal will see Hologic Inc. distributing a soft tissue biopsy instrument manufactured by Angiotech Pharmaceuticals Inc. Angiotech Pharmaceuticals Inc. (NSDQ:ANPI) inked a three-year ...
The Food and Drug Administration issued a warning letter to Hologic Inc. (NASDAQ:HOLX), citing violations in the manufacturing and reporting processes for its BioZorb product line. The letter, ...
Over the last 20 years, the NovaSure system has built a trusted legacy in GEA. The NovaSure device first received FDA approval in 2001, and by 2018 the NovaSure procedure had been used to treat over 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results